Mental Health Clinics in Loup City, NE Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Central Nebraska Community Services, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 626 N Street, Pob 509, Loup City, NE 68853 Phone: 308-745-0780 Fax: 308-745-0824 |
News Archive
A new, less toxic way to treat malignant melanoma
A new, less toxic way to treat malignant melanoma (skin cancer) is being developed by medicinal chemists at Reading University. They have produced a range of prodrugs: compounds that offer the potential to be converted to toxic molecules only within the vicinity of tumours. These prodrugs aim to reduce the toxicity of treatment.
Study shows new role of zinc in optic nerve injury
For more than two decades, researchers have tried to regenerate the injured optic nerve using different growth factors and/or agents that overcome natural growth inhibition.
Max Planck scientists identify unknown proteins of the herpesvirus
The genome encodes the complete information needed by an organism, including that required for protein production. Viruses, which are up to a thousand times smaller than human cells, have considerably smaller genomes. Using a type of herpesvirus as a model system, the scientists of the Max Planck Institute of Biochemistry in Martinsried near Munich and their collaboration partners at the University of California in San Francisco have shown that the genome of this virus contains much more information than previously assumed.
Some IVF techniques leading to more bundles in blue: Study
According to a new study by Australian researchers some infertility treatments may influence the sex of a baby to such an extent that increased uptake could upset the gender balance later. The study shows that a type of IVF treatment increases the chance of having a boy to as much as 56.1 per cent, while another treatment cuts it to 48.7 per cent.
Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).
› Verified 5 days ago